APA (7th ed.) Citation

Loomba, R., Hartman, M. L., Lawitz, E. J., Vuppalanchi, R., Boursier, J., Bugianesi, E., . . . Sanyal, A. J. (2024). Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis. New England Journal of Medicine, 391(4), 299. https://doi.org/10.1056/NEJMoa2401943

Chicago Style (17th ed.) Citation

Loomba, R., et al. "Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis." New England Journal of Medicine 391, no. 4 (2024): 299. https://doi.org/10.1056/NEJMoa2401943.

MLA (9th ed.) Citation

Loomba, R., et al. "Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis." New England Journal of Medicine, vol. 391, no. 4, 2024, p. 299, https://doi.org/10.1056/NEJMoa2401943.